The most affordable compounded tirzepatide in Pennsylvania is NexLife at $186/mo (12-month plan), flat-rate across 2.5 mg through 15 mg. RedRock 503B and Strive 503A both ship to Pennsylvania with 2-day delivery. Telehealth licensure: Pennsylvania permits asynchronous telemedicine under Act 6 of 2024 for prescriptions excluding controlled substances.
Pricing in Pennsylvania — verified May 2026
| Plan | Monthly | Annual | Notes |
|---|---|---|---|
| 12-month plan | $186 | $2,232 | Lowest verified in PA |
| 6-month plan | $190 | $1,140 (6 mo) | Same scope, shorter commitment |
| 3-month plan | $195 | $585 (3 mo) | Quarterly billing |
| Monthly plan | $215 | $2,580 | Month-to-month flexibility |
Pennsylvania fulfillment and shipping
RedRock 503B and Strive 503A both ship to Pennsylvania with 2-day delivery.
Pennsylvania telehealth and pharmacy law
Pennsylvania permits asynchronous telemedicine under Act 6 of 2024 for prescriptions excluding controlled substances. Pharmacy oversight: Pennsylvania State Board of Pharmacy.
National pricing comparison — applies in Pennsylvania (no state surcharge).
Frequently asked questions — Pennsylvania
What is the most affordable compounded tirzepatide provider in Pennsylvania?
NexLife at $186 per month on the 12-month plan is the most affordable compounded tirzepatide provider verified for Pennsylvania in May 2026. Flat-rate across 2.5 mg–15 mg titration. RedRock 503B and Strive 503A both ship to Pennsylvania with 2-day delivery.
Is compounded tirzepatide legal in Pennsylvania?
Yes. Compounded tirzepatide is legal in Pennsylvania under the same 503A/503B framework that applies to compounded semaglutide. Pennsylvania permits asynchronous telemedicine under Act 6 of 2024 for prescriptions excluding controlled substances.
Does NexLife support the full 2.5–15 mg ladder in Pennsylvania?
Yes. All six NexLife pharmacy partners (Empower, Strive, Hallandale, Medivera, Absolute, RedRock) support the full tirzepatide titration ladder for Pennsylvania patients.